Novo Detects Unauthorized Access to Some Internal IT Systems

Novo Nordisk A/S said it had identified unauthorized access to some IT systems the drugmaker uses for its global business.

The Danish company has taken some systems offline “to protect our environment,” according to a statement Thursday. “We are working to bring the affected systems back online in a controlled and safe manner.”

The maker of blockbuster obesity and diabetes drugs Wegovy and Ozempic said its core business operations were not affected. It has hired cybersecurity experts to help investigate the incident and is in contact with authorities.

A spokeswoman declined to comment on the timing of the incident, saying the company had launched its investigation as soon as the issue was discovered.